Stocks and Investing
Stocks and Investing
Wed, March 6, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Anupam Rama Maintained (SWTX) at Buy with Increased Target to $74 on, Mar 6th, 2024
Anupam Rama of JP Morgan, Maintained "SpringWorks Therapeutics, Inc." (SWTX) at Buy with Increased Target from $73 to $74 on, Mar 6th, 2024.
Anupam has made no other calls on SWTX in the last 4 months.
There are 3 other peers that have a rating on SWTX. Out of the 3 peers that are also analyzing SWTX, 0 agree with Anupam's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Anupam
- Peter Lawson of "Barclays" Maintained at Buy with Increased Target to $63 on, Thursday, February 29th, 2024
- David Nierengarten of "Wedbush" Maintained at Buy with Increased Target to $70 on, Monday, February 26th, 2024
- Corinne Jenkins of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $52 on, Wednesday, November 29th, 2023
Contributing Sources